KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbCellera Biologics (ABCL) Return on Invested Capital (2021 - 2026)

AbCellera Biologics filings provide 6 years of Return on Invested Capital readings, the most recent being 0.0% for Q1 2026.

  • Quarterly Return on Invested Capital changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Invested Capital hit 0.0% in Q1 2026 for AbCellera Biologics, up from 0.0% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.0% in Q3 2022 and bottomed at 0.0% in Q1 2025.
  • Average Return on Invested Capital over 5 years is 0.0%, with a median of 0.0% recorded in 2024.
  • Peak annual rise in Return on Invested Capital hit 0bps in 2022, while the deepest fall reached 0bps in 2022.
  • AbCellera Biologics' Return on Invested Capital stood at 0.0% in 2022, then crashed by -246bps to 0.0% in 2023, then plummeted by -45bps to 0.0% in 2024, then grew by 22bps to 0.0% in 2025, then increased by 1bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Return on Invested Capital are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).